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INTRODUCTION 
Oral candidiasis is one of the common fungal infections, 
affecting the oral mucosa. Candidiasis is defined as an 
infection caused by a fungi of the genus Candida, and 
the term oral candidiasis is only used when describing a 
clinically visible lesion in the oral cavity.
1
These lesions 
are caused by the yeast Candida albicans. The most 
prevalent Candida species involved in human infection 
is C. albicans. In oral candidiasis, C. albicans generally 
accounts for around 50% of cases.
2,3
 In the acquired 
human immunodeficiency syndrome (AIDS), it is known 
that among the opportunist infections, oral candidiasis is 
the most frequent one, and C. albicans, among others, 
has been very important in assessing the evolutionary 
behavior of the disease.
3 
The first case of acquired 
human immunodeficiency syndrome (AIDS) related in 
the literature mentions that the patient was an oral 
candidiasis carrier.
4 
In human immunodeficiency virus 
(HIV+) patients, nonspecific oral immunity is reduced, 
contributing to the frequent appearance of candidiasis.
5,6
 
Better stability and longer residence time will allow 
more of the antifungal to penetrate through the oral 
mucous layer to act on Candida species for longer 
duration of time. One way to improve the efficacy in 
eradicating the infection is to deliver the antifungal drug 
locally in the oral cavity. Therefore some researchers 
had prepared and reported new formulation such as gels, 
mucoadhesive tablets, pH sensitive excipients 
composition mucoadhesive microspheres, which were 
able to reside in oral cavity for an extended period for 
more effective candidiasis eradication.
7
The present 
investigation is designed to improve patient compliance 
and ease of administration. Advantages of the 
Clotrimazole jellies as dosage forms include increase in 
bioavailability, reduction in dose size, and in gastric 
irritation, bypass first pass metabolism. The present 
work is aimed at preparing a formulation of 
Clotrimazole jellies, for relief of oral candidiasis. 
MATERIALS AND METHODS 
Clotrimazole was received as a gift sample from M/s 
Alkem Laboratories Pvt. Ltd., Mumbai. Xanthan gum 
was obtained from Local market. Sucrose was brought 
from SD Fine Chemicals, Mumbai. Citric acid was 
received from CDH Pvt. Ltd., Mumbai. All other 
chemicals and solvents used are of analytical grade and 
used as procured. 
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Preparation of Medicated Jellies
 8 
All the formulations were prepared using freshly boiled 
and cooled distilled water as per the composition listed 
in Table 1. Clotrimazole jellies were prepared by heating 
and congealing method. Syrupy base was prepared in a 
copper vessel dissolving the required amounts of sugar 
in water on heating and stirring at 80°C for about 90 
min. accurately weighed polymer powder was dispersed 
in 10 mL of purified water maintained at 90
o
C 
throughout preparation. The dispersion was stirred using 
a magnetic stirrer (2MLH, Remi Equipment Pvt. Ltd., 
Mumbai, India) for 20 min to facilitate hydration of 
gelling agent. Clotrimazole was taken in another beaker 
and solubilized using alcohol. Then simple syrup was 
added to it under continuous stirring. Then citric acid 
and preservatives were added under continuous stirring. 
Color and flavor was added to this under continuous 
stirring at 60°C. The final weight was adjusted with 
purified water, mixed, transferred to polyethylene molds, 
sealed and allowed to cool at room temperature (25°C ± 
5°C) to form a jelly like texture. After the jelly is set it is 
wrapped in to the gelatin paper and store in dry place. 
 
Table 1: Working formulae to prepare Clotrimazole jellies
20 
Sl. No Ingredients (w/w) C0 C1 C2 C3 
01 Drug 0.2 0.2 0.2 0.2 
02 Xanthan gum - 0.5 1 1.5 
03 Citric acid 1 1 1 1 
04 Alcohol 5 5 5 5 
05 Methyl paraben 0.18 0.18 0.18 0.18 
06 Propyl paraben 0.02 0.02 0.02 0.02 
07 Color Q.S Q.S Q.S Q.S 
08 Flavor Q.S Q.S Q.S Q.S 
09 Sucrose 66.7 66.7 66.7 66.7 
10 Purified water 28.8 28.8 28.8 28.8 
11 Total weight 100 100 100 100 
* Each jelly contains 10 mg of Drug.                                                                                        * Each jelly weighs 05 gm. 
 
Characterization of prepared clotrimazole jellies 
Physical observation
9
 
The prepared jellies were observed visually for clarity, 
odor, texture and presence of any gritty particles. The 
texture was evaluated in terms of stickiness and 
grittiness by mild rubbing the jelly between two fingers. 
Weight variation
10
 
The average weight of ten jellies was taken to determine 
weight variation. The jellies were taken out of the molds 
in a beaker and weighed individually, pooled and mixed.  
Determination of pH
11, 12
 
The pH of the formulation influences the taste and 
stability of oral jellies. The pH of prepared jellies was 
measured using a digital pH meter (LI 120, Elico Ltd., 
Hyderabad, India) at room temperature (25°C ± 5°C). 
For this purpose, 0.5 g of jelly was dispersed in 50 mL 
of distilled water to make a 1% solution, and the pH was 
noted. 
Syneresis
13
 
Syneresis or de-swelling is usually seen in gels due to 
the release of liquid, resulting in shrinkage of gels and 
reduce quality. Syneresis is the contraction of the gel 
upon storage and separation of water from the gel. It is 
more pronounced in the gels, where lower concentration 
of gelling agent is employed. All the jellies were 
observed for signs of syneresis at room temp (25°C ± 
5°C). The formulations showing signs of syneresis were 
rejected and not considered for further studies. 
Drug-Excipient Compatibility Studies
14 
The drug and excipients were mixed together in 1:1 ratio 
and placed in borosilicate colored glass vials. These 
vials were sealed and placed in an oven maintained at 
40°C and 75% RH. The samples were observed after 15, 
30 and 45 days for any color change or lump formation. 
Fourier transforms infrared (FTIR) spectra of the pure 
drug and its mixtures of gelling agents were measured 
by preparing dispersion in dry KBr using attenuated 
total reflectance FTIR spectrophotometer (Bruker, UK). 
The absorption maxima in the spectra obtained were 
compared, and the presence of additional peaks 
corresponding to the functional groups was noted.  
Stability Studies
15, 16 
A physically stable medicated oral jelly should retain its 
viscosity, color, clarity, taste, and odor throughout its 
shelf-life. The stability studies were performed at two 
temperatures i.e., 37°C and 45°C over a period of six 
months. Sufficient number of samples (10) were packed 
in amber colored screw capped bottles and kept in 
incubator maintained at 37°C. Samples were taken at 
intervals of 15 days for the drug content estimation. 
In Vitro Drug Dissolution Studies
17, 18 
USP XXIII Dissolution test apparatus was used by 
taking 100 ml of pH 6.8 buffer in 1000 ml dissolution 
flask and jelly was placed in it, rotating paddle at a 
speed of 150 rpm and temperature 37±1ºC was 
maintained. 5 ml aliquots were withdrawn at 01, 02, 03, 
04, 05 and 06 minutes intervals, after each withdrawal 
of a sample an equal volume of dissolution medium was 
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added to the dissolution flask. The filtered samples were 
diluted and analyzed spectrophotometrically at 272.0 
nm. 
Antifungal Activity
19 
Microbiological studies were carried out to ascertain the 
antifungal activity of the prepared formulation as against 
the pure drug. Clotrimazole is known to possess superior 
antifungal activity against fungal infections. In present 
work, antifungal activity of clotrimazole was tested by 
using the yeast Candida albicans, which is the most 
frequently encountered human fungal pathogen being 
responsible for a wide range of superficial infections. 
The prepared jellies were evaluated for in vitro 
antifungal activity using standard Agar cup-plate 
method. 
RESULTS AND DISCUSSION 
Characterisation of Prepared Clotrimazole Jellies 
Physical observation 
Physical observation of jellies is important to justify the 
patient acceptance and compliance of the products. The 
observed parameters are summarized in Table 2.of all 
the formulations C3 showed best results being 
transparent and slightly sticky with an acceptable 
consistency.
 
Table 2:  Physicochemical parameters of Clotrimazole jellies 
 
Formulations 
Properties of jellies 
Appearance Consistency Texture pH of the jelly Syneresis 
(Room temp: 25
0
C± 5
0
C) 
C0 Transparent Slightly liquid Non-sticky 6.51±0.03 - 
C1 Cloudy Acceptable Sticky 6.25±0.05 - 
C2 Cloudy Acceptable Slightly sticky 6.32±0.08 - 
C3 Transparent Acceptable Slightly sticky 6.93±0.01 - 
* Each reading is a mean of three replicates.  
* Each jelly contains 10 mg of Clotrimazole 
* Each jelly weight of 5 gm 
* + positive; - negative 
 
Table 3: Antifungal studies showing the comparative zone of inhibition of drug as pure and in formulation (C3) 
Formulation Code 
Statistical Zone inhibition (mm) after 36 hrs Mean± S.D 
Zone 1 Zone 2 Zone 3 
Pure Drug 23 23 24 23.33±0.57 
C3 24 23 24 23.66±0.53 
 
 
Weight variation 
The weight variation was found between 4.97%±0.84% 
and 5.73%±0.63% in all prepared jelly formulations. 
Determination of pH 
The results of pH of prepared jelly formulations are 
summarized in Table 3. The pH of the formulation 
influences the taste and stability of oral jellies. The pH 
of the prepared formulations was found in the range of 
6.25±0.02-6.93±0.03 which was slightly acidic. Sucrose 
may precipitate in the presence of citric acid on 
standing. Therefore, a minimum quantity of citric acid 
was added just to maintain the pH. 
Syneresis 
Syneresis observed after 24 h of jelly preparation. None 
of the formulations showed syneresis at room 
temperature (25°C ± 5°C) (Table 2). 
Stability studies 
The samples were characterized for change in various 
parameters such as appearance, pH, sugar 
crystallization, stiffness, syneresis and drug content at 
the end of 90 days. A freshly made sample was used as a 
reference standard for subjective evaluations. 
Formulation C3 showed best results.  
In vitro dissolution testing 
The in vitro dissolution study was carried out to 
compare clotrimazole release kinetics from the prepared 
formulations. The results are summarized in Figure 1. C3 
showed optimal results.  
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Figure 1: in vitro studies of Clotrimazole medicated jellies 
*All values are in triplicates      *Each jelly contains 10 mg of Drug.          *Each jelly weighs 05 gm. 
 
                      
Pure drug                                                                  C3 
Figure 2: Photographs of antifungal studies showing the comparative zone of inhibition of drug as pure and in 
formulation (C3) 
 
Antifungal studies 
The anti-microbial study reveals that zone inhibition of 
promising formulations was found to be equal on 
comparison with the activity of pure drug. This indicates 
that there is no change in the molecular activity of the 
drug present in the formulations. The results are 
summarized in table 3. 
CONCLUSION 
It is found that sucrose based Medicated jellies will be 
ideal dosage forms for elderly and pediatrics patients. 
These will have additional advantages of efficient 
treatment including low dose, ease of administration, 
immediate onset of action, reduced dosage regimen and 
economic. The Physico-chemical characterization 
revealed that all the formulations were found to be 
shown acceptable weight variation, pH and syneresis. 
The drug content estimation showed uniform drug 
content in all the formulations. IR spectroscopic studies 
indicated that there were no drug-excipients interactions. 
Addition of polymers like xanthan gum yield good 
results to prolong dissolution time and the drug release 
in salivary pH conditions for a period of 30 minutes. The 
stability studies proved that the prepared Medicated 
jellies were found to be stable when stored at air tight 
containers or twist strips. The antifungal study reveals 
that zone inhibition of various prepared formulations 
was found to be equal on comparison with the activity of 
pure drug. This indicates that there is no change in the 
molecular activity of the drug present in the 
formulations. The present work on Medicated Jellies 
offer patient convenience and compliance and ease of 
administration in application. 
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